VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ histologically proven prostate adenocarcinoma      │ histologically proven prostate adenocarcinoma      │     100 │
│ within 1 year of enrollment                        │ within 1 year of enrollment                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ ECOG Performance Status 0-1                        │ ECOG Performance Status 0-1                        │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ No prior prostate radiation or other definitive    │ No prior prostate radiation or other definitive    │     100 │
│ therapy                                            │ therapy                                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ implanted hardware or other material that would    │ implanted hardware or other material that would    │     100 │
│ prohibit treatment planning or delivery            │ prohibit treatment planning or delivery            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ chemotherapy for a malignancy within the previous  │ chemotherapy for a malignancy within the previous  │     100 │
│ 5 years                                            │ 5 years                                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ history of an invasive malignancy (other than this │ history of an invasive malignancy (other than this │     100 │
│ prostate cancer,or basal or squamous skin cancers) │ prostate cancer,or basal or squamous skin cancers) │         │
│ within prior 5 years                               │ within prior 5 years                               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ hormone ablation for 2 months prior to treatment   │ hormone ablation for 2 months prior to treatment   │     100 │
│ or during treatment                                │ or during treatment                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Intermediate risk:Gleason \<or=6 \& PSA\<or=10 \&  │ Intermediate risk:Gleason <or=6 & PSA<or=10 &      │      97 │
│ Clinical Stage T2b OR Gleason=7 \& PSA\<or=10 \&   │ Clinical Stage T2b OR Gleason=7 & PSA<or=10 &      │         │
│ Clinical Stage T1b-T2b OR Gleason \<or=6 \& PSA \> │ Clinical Stage T1b-T2b OR Gleason <or=6 & PSA > 10 │         │
│ 10 \& \< or =20 \& Clinical Stage T1b- T2b, Nx or  │ & < or =20 & Clinical Stage T1b- T2b, Nx or NO, Mx │         │
│ NO, Mx or M0                                       │ or M0                                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Low risk: Gleason \<or=6 \& PSA \<or=10 \&         │ Low risk: Gleason <or=6 & PSA <or=10 & Clinical    │      98 │
│ Clinical Stage T1b-T2a,Nx or N0, Mx or M0          │ Stage T1b-T2a,Nx or N0, Mx or M0                   │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤═══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                     │   Score │
╞═══════════════════════════════════╪═══════════════════════════════════════════════════╪═════════╡
│ Must be MALE                      │ ECOG Performance Status 0-1                       │      15 │
├───────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 21 Years │ chemotherapy for a malignancy within the previous │      40 │
│                                   │ 5 years                                           │         │
╘═══════════════════════════════════╧═══════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 96
Average Levenshtein Ratio of individual lines: 86.36363636363636
OverAll Ratio: 91.18181818181819
